Economic_NewsAstraZeneca wins shareholder approval for New York listing Rutt ontrd1 year ago01 mins Post Views: 250 Move by FTSE’s biggest company gains support of 99% of shareholders who voted in blow to London market 0 Reviews Post navigation Previous: AstraZeneca wins vote to press ahead with New York listingNext: Gold Price Forecast: XAU/USD failing to retain $4,000 amid broad US Dollar demand
Japan reports cooler-than-expected core inflation in October of 2.2% — but highest this year so far Rutt ontrd4 hours ago 0